CytoMed Therapeutics Limited (GDTC) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 3.66M | 3.21M | 3.04M | 4.39M | 4.67M | 5.68M | 5.71M | 7.65M | 7.39M | 8.48M | 8.62M | 1.86M |
| Cash & Short-Term Investments | 2.1M | 2.25M | 2.13M | 3.64M | 3.87M | 5.03M | 5.06M | 6.82M | 6.58M | 7.72M | 7.84M | 1.18M |
| Cash Only | 2.1M | 2.25M | 2.13M | 3.64M | 3.87M | 4.77M | 4.8M | 6.82M | 6.58M | 7.72M | 7.84M | 1.18M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 259.02K | 260.4K | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 132.05K | 965.91K | 914.17K | 13.75K | 14.61K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | 383.5 | 809.27 | 417.39 | 24.89 | 12.38 | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 614.2K | 652.68K | 530.17K | 532.99K | 514.32K | 496.48K | 0 | 0 | 430.17K |
| Days Inventory Outstanding | - | - | - | 5.52K | 4.85K | 390.51 | 58.22K | 51.78K | 52.69K | - | - | 978.21 |
| Other Current Assets | 0 | 0 | 0 | 97.3K | 103.39K | 36.02K | 36.21K | 199.92K | 192.99K | 762.41K | 774.75K | 218.61K |
| Total Non-Current Assets | 4.32M | 3.36M | 3.18M | 2.98M | 3.16M | 2.36M | 2.37M | 1.72M | 1.66M | 1.81M | 1.84M | 2.04M |
| Property, Plant & Equipment | 3.69M | 2.73M | 2.58M | 2.38M | 2.53M | 1.83M | 1.84M | 1.56M | 1.51M | 1.64M | 1.66M | 1.85M |
| Fixed Asset Turnover | 0.04x | 0.04x | 0.04x | 0.02x | 0.05x | 0.05x | 0.05x | 0.06x | 0.05x | 0.06x | 0.06x | 0.06x |
| Goodwill | 355 | 0 | 0 | 260 | 276 | 262 | 263 | 269 | 260 | 263 | 267 | 265 |
| Intangible Assets | 124.54K | 57.06K | 54.01K | 67.87K | 72.13K | 7.86K | 7.9K | 9.14K | 8.82K | 9.95K | 10.11K | 13.78K |
| Long-Term Investments | 18.21K | 179.75K | 170.12K | 161.78K | 171.92K | 155.62K | 156.45K | 147.82K | 142.69K | 162.43K | 165.06K | 178.75K |
| Other Non-Current Assets | 487.28K | 393.23K | 372.16K | 366.11K | 389.05K | 368.75K | 370.71K | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 7.98M | 6.57M | 6.22M | 7.37M | 7.83M | 8.05M | 8.09M | 9.37M | 9.05M | 10.29M | 10.46M | 3.9M |
| Asset Turnover | 0.02x | 0.02x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.03x |
| Asset Growth % | 8.32% | -18.31% | -23.1% | -21.35% | -13.42% | -21.8% | -22.64% | 140.17% | 148.6% | 177.41% | 174.98% | -13.47% |
| Total Current Liabilities | 709.17K | 552.95K | 523.33K | 444.18K | 472.01K | 263.96K | 265.37K | 543.28K | 524.43K | 232.84K | 236.6K | 3.11M |
| Accounts Payable | 124.74K | 375.68K | 355.56K | 28.29K | 30.06K | 33.06K | 33.24K | 18.65K | 18.01K | 45.44K | 46.18K | 10.92K |
| Days Payables Outstanding | 40.57 | 4.54K | 2.49K | 254.21 | 258.8 | 24.35 | 2.88K | 1.88K | 3.37K | 27.43 | 1.12K | 24.83 |
| Short-Term Debt | 40.85K | 30.09K | 28.48K | 27.57K | 29.3K | 25.68K | 25.82K | 25.71K | 24.82K | 24.74K | 25.14K | 2.79M |
| Deferred Revenue (Current) | 182.81K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 25.06K | 131.78K | 124.72K | 115.97K | 123.24K | 25.16K | 25.3K | 155.68K | 150.28K | 19.05K | 19.36K | 126.69K |
| Current Ratio | 5.17x | 5.81x | 5.81x | 9.89x | 9.89x | 21.53x | 21.53x | 14.08x | 14.08x | 36.42x | 36.42x | 0.60x |
| Quick Ratio | 5.17x | 5.81x | 5.81x | 8.51x | 8.51x | 19.53x | 19.53x | 13.14x | 13.14x | 36.42x | 36.42x | 0.46x |
| Cash Conversion Cycle | - | - | - | 5.29K | 4.6K | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 422.12K | 339.56K | 321.38K | 305.58K | 324.73K | 288.28K | 289.82K | 309K | 298.28K | 318.85K | 324.01K | 355.04K |
| Long-Term Debt | 368.66K | 292.95K | 277.26K | 288.72K | 306.81K | 288.28K | 289.82K | 309K | 298.28K | 316.94K | 322.07K | 350.03K |
| Capital Lease Obligations | 53.46K | 46.61K | 44.11K | 16.86K | 17.92K | 0 | 0 | 0 | 0 | 1.91K | 1.94K | 5.01K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 1.13M | 892.51K | 844.7K | 749.76K | 796.74K | 552.25K | 555.18K | 852.28K | 822.71K | 551.68K | 560.61K | 3.46M |
| Total Debt | 482.56K | 385.05K | 364.42K | 339.2K | 360.45K | 315.86K | 317.54K | 339.5K | 327.72K | 349.14K | 354.79K | 3.15M |
| Net Debt | -1.61M | -1.86M | -1.76M | -3.3M | -3.51M | -4.46M | -4.48M | -6.48M | -6.25M | -7.37M | -7.49M | 1.97M |
| Debt / Equity | 0.07x | 0.07x | 0.07x | 0.05x | 0.05x | 0.04x | 0.04x | 0.04x | 0.04x | 0.04x | 0.04x | 7.20x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -223.13x | -112.34x | -215.86x | -68.41x | - | -111.65x | - | -185.51x | - | -51.47x | - | -32.63x |
| Total Equity | 6.85M | 5.68M | 5.38M | 6.62M | 7.04M | 7.49M | 7.53M | 8.52M | 8.22M | 9.74M | 9.9M | 437.73K |
| Equity Growth % | 3.5% | -24.2% | -28.64% | -22.28% | -14.44% | -23.04% | -23.87% | 1846.51% | 1914.79% | 767.84% | 760.24% | -77.22% |
| Book Value per Share | 0.58 | 0.48 | 0.46 | 0.57 | 0.61 | 0.65 | 0.65 | 0.74 | 0.71 | 0.84 | 1.02 | 0.04 |
| Total Shareholders' Equity | 6.54M | 5.62M | 5.32M | 6.57M | 6.98M | 7.49M | 7.53M | 8.52M | 8.23M | 9.74M | 9.9M | 438.24K |
| Common Stock | 24.66M | 18.71M | 17.71M | 17.42M | 18.51M | 17.55M | 17.64M | 17.97M | 17.35M | 17.54M | 17.82M | 6.65M |
| Retained Earnings | -18.83M | -13.44M | -12.72M | -10.87M | -11.55M | -9.9M | -9.95M | -9.34M | -9.02M | -7.66M | -7.78M | -6.12M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 604.9K | 349.55K | 330.83K | 14.81K | 15.74K | -156.35K | -157.19K | -108.72K | -104.95K | -143.23K | -145.55K | -95.18K |
| Minority Interest | 309.22K | 59.52K | 56.33K | 56.93K | 60.5K | -811 | -816 | -724 | -699 | -607 | -617 | -509 |